Functional dyspepsia: a review of scientific and policy issues

Fujian Song and Alan Maynard

No 119chedp, Working Papers from Centre for Health Economics, University of York

Abstract: Functional dyspepsia can be defined as chronic or recurrent upper abdominal pain or discomfort, for which no focal lesion or systemic disease can be found. It is a common complaint seen by physicians and, although it does not cause death or severe disability in the majority of cases, represents an important and costly health problem. It is estimated that each year the total pharmaceutical cost for function dyspepsia ranges from £4.88 million to £41.84 million in England and Wales. The effect of treatment with various agents for function dyspepsia has not been convincingly evaluated, mainly because of lack of validated outcome measures and heterogeneity in patients. However, evidence from clinical trials suggests that prokinetic agents may help to improve symptoms in the short term among patients with dysmotility-like dyspepsia. The role of anti-secretory agents and treatment of Helicobacter pylori is less clear. Antacids do not relieve symptoms of functional dyspepsia more effectively than placebo. Due to great heterogeneity in patients with functional dyspepsia and the uncertainty of treatment effects, a variation in clinical management of dyspepsia is to be expected. Because there is a large pool of patients with dyspepsia, the potential growth of demand for investigation and treatment services for dyspepsia is great.

Keywords: dyspepsia; pharmaceuticals (search for similar items in EconPapers)
Pages: 40 pages
Date: 1994-05
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.york.ac.uk/media/che/documents/papers/d ... on%20Paper%20119.pdf First version, 1994 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:chy:respap:119chedp

Access Statistics for this paper

More papers in Working Papers from Centre for Health Economics, University of York Contact information at EDIRC.
Bibliographic data for series maintained by Gill Forder ().